Thanks Toinv

Something I should have added is that it is reasonable to expect a RVX bounce if news regarding Zenith materializes. This was talked about in the scrum that followed. Many RVX investors thought that there was some reasonable expectation that we would have already had news about a sale/M&A or some other partnership with Zenith and Pharma during the time between the the last two AGMs. It seems that one thing that may have delayed this happening was continued good news on the research front regarding ZEN-3694 which, in my opinion, may have changed valuations and prospects for Zenith. I am only guessing but it seems possible that current talks regarding Zenith appear to have Don and others very upbeat and energized. The study below is the one that was singled out and is largely behind recent optimism regarding Zenith:

Modulating BET Bromodomain Inhibitor ZEN-3694 and Enzalutamide Combination Dosing in a Metastatic Prostate Cancer Patient Using CURATE.AL Artificial Intelligence

 https://onlinelibrary.wiley.com/doi/abs/10.1002/adtp.201800104

Perhaps what happens with Zenith is part of the strategy that would return some equity to RVX investors while also avoiding the need for a reverse split of RVX stock. Maybe this is more of a hope, but if squinting and reading though the lines means anything, my impression was that such a scenario should be considered as a real possibility.